Don t show me this message again✕
The international phase three trial involved 200 sites in 26 countries (PA)
Patients with particularly aggressive prostate cancers can be treated more effectively by a combination of existing targeted medicine and an experimental new drug, new research suggests.
Researchers looked at the efficacy of the targeted hormone drug abiraterone together with a new drug called ipatasertib in patients with advanced prostate cancer who had received no prior treatment.
Abiraterone is a standard medicine taken by many people with advanced prostate cancer. The study, published in The Lancet, found using both medications extended the time before the cancer progressed and spread further.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis | Critical Care Medicine | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.
Stelling returns for fourth March for Men
safc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from safc.com Daily Mail and Mail on Sunday newspapers.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
This week, these are the loved ones remembered in the funeral notices and family announcements in The Sentinel.
To see the full list of family announcements, visit this section of the StokeonTrentLive website where you can search by name, date and location. You can also post your own announcements and notices there.
You can also see the latest listings from your area on the InYourArea section.